rts logo

Windtree Therapeutics Inc (WINT) Looks Ready for Growth Despite -54.19% Change This Year

Windtree Therapeutics Inc (NASDAQ: WINT) is -54.19% lower on its value in year-to-date trading and has touched a low of $0.10 and a high of $14.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The WINT stock was last observed hovering at around $0.14 in the last trading session, with the day’s gains setting it 0.02%.

Currently trading at $0.16, the stock is -4.46% and -44.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 29.66 million and changing 13.15% at the moment leaves the stock -94.73% off its SMA200. WINT registered -97.55% loss for a year compared to 6-month loss of -98.71%. The firm has a 50-day simple moving average (SMA 50) of $0.294 and a 200-day simple moving average (SMA200) of $3.0599.

The stock witnessed a -37.30% gain in the last 1 month and extending the period to 3 months gives it a -73.80%, and is 33.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 24.98% over the week and 20.39% over the month.

Windtree Therapeutics Inc (WINT) has around 15 employees, a market worth around $1.77M and $0.00M in sales. Distance from 52-week low is 52.96% and -98.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-146.00%).

The EPS is expected to grow by 94.00% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.

Windtree Therapeutics Inc (WINT) Top Institutional Holders

9.0 institutions hold shares in Windtree Therapeutics Inc (WINT), with institutional investors hold 2.07% of the company’s shares. The shares outstanding are 11.05M, and float is at 11.00M with Short Float at 8.26%. Institutions hold 2.06% of the Float.

Windtree Therapeutics Inc (WINT) Insider Activity

The most recent transaction is an insider purchase by Fraser Craig,the company’sPresident and CEO. SEC filings show that Fraser Craig bought 5,431 shares of the company’s common stock on Oct 08 ’24 at a price of $0.91 per share for a total of $4942.0. Following the purchase, the insider now owns 8638.0 shares.

Related Posts